Skip to main content
Journal cover image

YAP1 plays a key role of the conversion of normal fibroblasts into cancer-associated fibroblasts that contribute to prostate cancer progression.

Publication ,  Journal Article
Shen, T; Li, Y; Zhu, S; Yu, J; Zhang, B; Chen, X; Zhang, Z; Ma, Y; Niu, Y; Shang, Z
Published in: Journal of experimental & clinical cancer research : CR
February 2020

Cancer-associated fibroblasts (CAFs) are an important part of the tumour microenvironment, and their functions are of great concern. This series of experiments aimed to explore how Yes-associated protein 1 (YAP1) regulates the function of stromal cells and how the normal fibroblasts (NFs) convert into CAFs in prostate cancer (PCa).The effects of conditioned media from different fibroblasts on the proliferation and invasion of epithelial cells TrampC1 were examined. We then analysed the interaction between the YAP1/TEAD1 protein complex and SRC, as well as the regulatory function of the downstream cytoskeletal proteins and actins. A transplanted tumour model was used to explore the function of YAP1 in regulating tumour growth through stromal cells. The relationship between the expression of YAP1 in tumour stromal cells and the clinical characteristics of PCa patients was analysed.The expression level of YAP1 was significantly upregulated in PCa stromal cells. After the expression level of YAP1 was increased, NF was transformed into CAF, enhancing the proliferation and invasion ability of epithelial cells. The YAP1/TEAD1 protein complex had the capability to influence downstream cytoskeletal proteins by regulating SRC transcription; therefore, it converts NF to CAF, and CAF can significantly promote tumour growth and metastasis. The high expression of YAP1 in the tumour stromal cells suggested a poor tumour stage and prognosis in PCa patients.YAP1 can convert NFs into CAFs in the tumour microenvironment of PCa, thus promoting the development and metastasis of PCa. Silencing YAP1 in tumour stromal cells can effectively inhibit tumour growth.

Duke Scholars

Published In

Journal of experimental & clinical cancer research : CR

DOI

EISSN

1756-9966

ISSN

0392-9078

Publication Date

February 2020

Volume

39

Issue

1

Start / End Page

36

Related Subject Headings

  • YAP-Signaling Proteins
  • Xenograft Model Antitumor Assays
  • Transcription Factors
  • TEA Domain Transcription Factors
  • Protein Binding
  • Prostatic Neoplasms
  • Nuclear Proteins
  • Neoplasm Staging
  • Models, Biological
  • Mice
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Shen, T., Li, Y., Zhu, S., Yu, J., Zhang, B., Chen, X., … Shang, Z. (2020). YAP1 plays a key role of the conversion of normal fibroblasts into cancer-associated fibroblasts that contribute to prostate cancer progression. Journal of Experimental & Clinical Cancer Research : CR, 39(1), 36. https://doi.org/10.1186/s13046-020-1542-z
Shen, Tianyu, Yang Li, Shimiao Zhu, Jianpeng Yu, Boya Zhang, Xuanrong Chen, Zheng Zhang, Yuan Ma, Yuanjie Niu, and Zhiqun Shang. “YAP1 plays a key role of the conversion of normal fibroblasts into cancer-associated fibroblasts that contribute to prostate cancer progression.Journal of Experimental & Clinical Cancer Research : CR 39, no. 1 (February 2020): 36. https://doi.org/10.1186/s13046-020-1542-z.
Shen T, Li Y, Zhu S, Yu J, Zhang B, Chen X, et al. YAP1 plays a key role of the conversion of normal fibroblasts into cancer-associated fibroblasts that contribute to prostate cancer progression. Journal of experimental & clinical cancer research : CR. 2020 Feb;39(1):36.
Shen, Tianyu, et al. “YAP1 plays a key role of the conversion of normal fibroblasts into cancer-associated fibroblasts that contribute to prostate cancer progression.Journal of Experimental & Clinical Cancer Research : CR, vol. 39, no. 1, Feb. 2020, p. 36. Epmc, doi:10.1186/s13046-020-1542-z.
Shen T, Li Y, Zhu S, Yu J, Zhang B, Chen X, Zhang Z, Ma Y, Niu Y, Shang Z. YAP1 plays a key role of the conversion of normal fibroblasts into cancer-associated fibroblasts that contribute to prostate cancer progression. Journal of experimental & clinical cancer research : CR. 2020 Feb;39(1):36.
Journal cover image

Published In

Journal of experimental & clinical cancer research : CR

DOI

EISSN

1756-9966

ISSN

0392-9078

Publication Date

February 2020

Volume

39

Issue

1

Start / End Page

36

Related Subject Headings

  • YAP-Signaling Proteins
  • Xenograft Model Antitumor Assays
  • Transcription Factors
  • TEA Domain Transcription Factors
  • Protein Binding
  • Prostatic Neoplasms
  • Nuclear Proteins
  • Neoplasm Staging
  • Models, Biological
  • Mice